Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada

NCT03784898 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

OTHER: Blood draw for future biomarker analysis

Sponsor

Genzyme, a Sanofi Company